Birchview Capital, LP - CONCERT PHARMACEUTICALS INC ownership

CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 55 filers reported holding CONCERT PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.58 and the average weighting 0.0%.

Quarter-by-quarter ownership
Birchview Capital, LP ownership history of CONCERT PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$117
-99.9%
20,0000.0%0.08%
-11.7%
Q3 2022$134,000
+59.5%
20,0000.0%0.09%
+54.1%
Q2 2022$84,000
+25.4%
20,0000.0%0.06%
+27.1%
Q1 2022$67,000
+6.3%
20,0000.0%0.05%
+17.1%
Q4 2021$63,000
-3.1%
20,0000.0%0.04%
-6.8%
Q3 2021$65,000
-22.6%
20,0000.0%0.04%
-12.0%
Q2 2021$84,000
-16.0%
20,0000.0%0.05%
-15.3%
Q1 2021$100,00020,0000.06%
Other shareholders
CONCERT PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Kynam Capital Management, LP 4,420,349$25,814,8383.96%
Parkman Healthcare Partners LLC 1,203,484$7,028,3471.87%
SPHERA FUNDS MANAGEMENT LTD. 1,002,783$5,856,2531.26%
TANG CAPITAL MANAGEMENT LLC 1,150,000$6,716,0000.98%
BVF INC/IL 3,629,000$21,193,3600.89%
Nantahala Capital Management 1,732,388$10,117,1460.66%
AWM Investment Company, Inc. 666,661$3,893,3000.56%
INGALLS & SNYDER LLC 1,295,833$7,5680.41%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 200,800$1,172,6720.36%
Kensington Investment Counsel, LLC 58,599$342,2180.27%
View complete list of CONCERT PHARMACEUTICALS INC shareholders